Patient 2 with decompensated cirrhosis due to alcohol with short duration of sobriety.
作者信息
Lindenmeyer Christina C, Welch Nicole, Carey William D
机构信息
Department of Gastroenterology and Hepatology Cleveland Clinic Cleveland OH.
出版信息
Clin Liver Dis (Hoboken). 2018 Jul 26;11(6):152-155. doi: 10.1002/cld.706. eCollection 2018 Jun.
Abstract
摘要
相似文献
1
Patient 2 with decompensated cirrhosis due to alcohol with short duration of sobriety.患者2，因酒精性肝硬化失代偿，戒酒时间短。
Clin Liver Dis (Hoboken). 2018 Jul 26;11(6):152-155. doi: 10.1002/cld.706. eCollection 2018 Jun.
2
The contribution of alcohol use disorder to decompensated cirrhosis among people with hepatitis C: An international study.酒精使用障碍在丙型肝炎患者失代偿性肝硬化中的作用：一项国际研究。
J Hepatol. 2018 Mar;68(3):393-401. doi: 10.1016/j.jhep.2017.10.019. Epub 2017 Oct 26.
3
Outcome of liver transplantation in critically ill patients with alcoholic cirrhosis: survival according to medical variables and sobriety.重症酒精性肝硬化患者肝移植的结局：根据医学变量和戒酒情况的生存率
Transplantation. 1998 Aug 15;66(3):298-302. doi: 10.1097/00007890-199808150-00004.
4
Sobriety Checkpoints and Alcohol-Involved Motor Vehicle Crashes at Different Temporal Scales.不同时间尺度下的清醒点检查和涉及酒精的机动车事故。
Am J Prev Med. 2019 Jun;56(6):795-802. doi: 10.1016/j.amepre.2019.01.015. Epub 2019 Apr 17.
5
Publicized sobriety checkpoint programs: a community guide systematic review.公开的清醒检查站计划：社区指南系统评价
Am J Prev Med. 2014 May;46(5):529-39. doi: 10.1016/j.amepre.2014.01.018.
6
Patient-reported outcomes with sofosbuvir and velpatasvir with or without ribavirin for hepatitis C virus-related decompensated cirrhosis: an exploratory analysis from the randomised, open-label ASTRAL-4 phase 3 trial.索磷布韦和维帕他韦联合或不联合利巴韦林治疗丙型肝炎病毒相关失代偿性肝硬化的患者报告结局：来自随机、开放标签 ASTRAL-4 期 3 期试验的探索性分析。
Lancet Gastroenterol Hepatol. 2016 Oct;1(2):122-132. doi: 10.1016/S2468-1253(16)30009-7. Epub 2016 Aug 3.
7
Sofosbuvir and Velpatasvir Combination Improves Patient-reported Outcomes for Patients With HCV Infection, Without or With Compensated or Decompensated Cirrhosis.索磷布韦和维帕他韦联合治疗可改善 HCV 感染患者的患者报告结局，无论患者是否伴有代偿或失代偿性肝硬化。
Clin Gastroenterol Hepatol. 2017 Mar;15(3):421-430.e6. doi: 10.1016/j.cgh.2016.10.037. Epub 2016 Nov 12.
8
Utility of Platelet Count for Predicting Cirrhosis in Alcoholic Liver Disease: Model for Identifying Cirrhosis in a US Population.血小板计数对预测酒精性肝病肝硬化的效用：美国人群肝硬化识别模型
J Gen Intern Med. 2015 Aug;30(8):1112-7. doi: 10.1007/s11606-015-3238-1. Epub 2015 Feb 21.
9
The reliability of alcoholism history in patients with alcohol-related cirrhosis.酒精性肝硬化患者酒精成瘾史的可靠性。
Alcohol Alcohol. 1998 Sep-Oct;33(5):488-94. doi: 10.1093/alcalc/33.5.488.
10
Predictors of mortality among patients with compensated and decompensated liver cirrhosis: the role of bacterial infections and infection-related acute-on-chronic liver failure.代偿期和失代偿期肝硬化患者的死亡预测因素：细菌感染及感染相关慢加急性肝衰竭的作用
Scand J Gastroenterol. 2015 Jul;50(7):875-83. doi: 10.3109/00365521.2015.1017834. Epub 2015 Feb 19.
本文引用的文献
1
Systematic review with meta-analysis: post-operative complications and mortality risk in liver transplant candidates with obesity.系统评价与荟萃分析：肥胖肝移植受者的术后并发症及死亡风险
Aliment Pharmacol Ther. 2017 Aug;46(3):236-245. doi: 10.1111/apt.14139. Epub 2017 May 10.
2
Liver transplantation for patients with alcoholic hepatitis.肝移植治疗酒精性肝炎。
Liver Int. 2017 Mar;37(3):337-339. doi: 10.1111/liv.13248.
3
Ohio solid organ transplantation consortium criteria for liver transplantation in patients with alcoholic liver disease.俄亥俄州实体器官移植联盟关于酒精性肝病患者肝移植的标准
World J Hepatol. 2016 Sep 28;8(27):1149-1154. doi: 10.4254/wjh.v8.i27.1149.
4
Liver Transplantation for Alcoholic Liver Disease.酒精性肝病的肝移植
Transplantation. 2016 May;100(5):981-7. doi: 10.1097/TP.0000000000001156.
5
Recidivism in Liver Transplant Recipients With Alcoholic Liver Disease: Analysis of Demographic, Psychosocial, and Histology Features.酒精性肝病肝移植受者的复发：人口统计学、心理社会和组织学特征分析
Exp Clin Transplant. 2015 Oct;13(5):430-40.
6
DSM-5 criteria for substance use disorders: recommendations and rationale.DSM-5 物质使用障碍标准：建议和原理。
Am J Psychiatry. 2013 Aug;170(8):834-51. doi: 10.1176/appi.ajp.2013.12060782.
7
EASL clinical practical guidelines: management of alcoholic liver disease.欧洲肝脏研究学会临床实践指南：酒精性肝病的管理
J Hepatol. 2012 Aug;57(2):399-420. doi: 10.1016/j.jhep.2012.04.004. Epub 2012 May 26.
8
Metabolic syndrome in liver transplant recipients: prevalence, risk factors, and association with cardiovascular events.肝移植受者的代谢综合征：患病率、危险因素及与心血管事件的关系。
Liver Transpl. 2011 Jan;17(1):15-22. doi: 10.1002/lt.22198.
9
Trajectories of alcohol consumption following liver transplantation.肝移植后饮酒轨迹。
Am J Transplant. 2010 Oct;10(10):2305-12. doi: 10.1111/j.1600-6143.2010.03232.x. Epub 2010 Aug 19.
10
Outcomes of liver transplantation in patients with cirrhosis due to nonalcoholic steatohepatitis versus patients with cirrhosis due to alcoholic liver disease.非酒精性脂肪性肝炎相关肝硬化与酒精性肝病相关肝硬化患者行肝移植的结局比较。
Liver Transpl. 2009 Dec;15(12):1814-20. doi: 10.1002/lt.21927.
Zotero 插件